Absorption of orally administered neomycin and kanamycin; with special reference to patients with severe hepatic and renal disease.
D000900:Anti-Bacterial Agents / Q000628:therapy*; D006801:Humans; D007612:Kanamycin; D007674:Kidney Diseases / Q000628:therapy*; D008107:Liver Diseases / Q000628:therapy*; D009355:Neomycin / Q000628:therapy*
D000900:Anti-Bacterial Agents; D007612:Kanamycin; D009355:Neomycin
ANTIBIOTICS/therapy; KIDNEY DISEASES/therapy; LIVER DISEASES/therapy; NEOMYCIN/therapy